BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/13/2017 1:26:13 AM | Browse: 274 | Download: 158
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 33296
Country of Manuscript Source Australia
2017-02-08 10:35
Peer-Review Started
2017-02-08 14:46
To Make the First Decision
2017-05-08 15:34
Return for Revision
2017-05-16 08:25
2017-06-26 17:36
Second Decision
2017-08-10 03:35
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2017-08-17 03:03
Articles in Press
2017-08-17 03:03
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2017-09-21 03:04
Publish the Manuscript Online
2017-10-13 01:26
ISSN 1948-5204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Specialty Oncology
Manuscript type Review
Article Title Ampullary cancer of intestinal origin and duodenal cancer - A logical clinical and therapeutic subgroup in periampullary cancer
Manuscript Source Invited Manuscript
All Author List Manju D Chandrasegaram, Anthony J Gill, Jas Samra, Tim Price, John Chen, Jonathan Fawcett and Neil D Merrett
Funding Agency and Grant Number
Correspondence To Manju D Chandrasegaram, Dr., The Prince Charles Hospital, Rode Road, Chermside, Queensland 4032, Australia. m.chandrasegaram@uq.edu.au
Keywords Periampullary cancer; Pancreatobiliary subtype; Intestinal subtype; Ampullary cancer; Duodenal cancer; Epidermal growth factor receptor; Pancreatic cancer; Chemotherapy; Pancreaticoduodenectomy; KRAS
Core Tip Periampullary cancers include pancreatic, ampullary, bile duct and duodenal cancers. Pancreatic cancer is the most common cancer resected with a pancreaticoduodenectomy followed by ampullary, bile duct and duodenal cancer. Patients with resected duodenal and ampullary cancers have better prognosis compared to pancreatic cancer. Ampullary cancers can be subdivided into intestinal or pancreatobiliary subtype cancers with histomolecular staining. Histomolecular profiling is superior to anatomic location in prognosticating survival. Ampullary cancers of intestinal subtype and duodenal cancers are similar in their intestinal origin and form a logical clinical and therapeutic subgroup. They respond to 5-FU based chemotherapeutic regimens such as capecitabine-oxaliplatin.
Publish Date 2017-10-13 01:26
Citation Chandrasegaram MD, Gill AJ, Samra J, Price T, Chen J, Fawcett J, Merrett ND. Ampullary cancer of intestinal origin and duodenal cancer - A logical clinical and therapeutic subgroup in periampullary cancer. World J Gastrointest Oncol 2017; 9(10): 407-415
Url http://www.wjgnet.com/1948-5204/full/v9/i10/407.htm
DOI http://dx.doi.org/10.4251/wjgo.v9.i10.407
Full Article (PDF) WJGO-9-407.pdf
Full Article (Word) WJGO-9-407.doc
Manuscript File 33296-Revew.docx
Answering Reviewers 33296-Answering reviewers.pdf
Audio Core Tip 33296-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 33296-Conflict-of-interest statement.pdf
Copyright License Agreement 33296-Copyright assignment.pdf
Peer-review Report 33296-Peer-review(s).pdf
Scientific Misconduct Check 33296-Scientific misconduct check.pdf
Scientific Editor Work List 33296-Scientific editor work list.pdf